To ask the Secretary of State for Health and Social Care, what steps he is taking to align NICE appraisal timelines, MHRA regulatory pathways and NHS commissioning decisions to support the delivery of personalised cancer medicines.
The National Institute for Health and Care Excellence (NICE) aims to issue guidance on new medicines close to the time of licensing to ensure that patients benefit from rapid access to clinically and cost effective new medicines. The National Health Servi...
Cancer: Drugs